Viewing Study NCT04250051


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-01-04 @ 2:12 PM
Study NCT ID: NCT04250051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-13
First Post: 2020-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Northwestern University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module